Abstract
HEV generally causes mild, self-limiting hepatitis E that may lead to acute or fulminant liver failure, chronicity and cirrhosis in some individuals. Pregnancy can further exacerbate hepatitis E, affecting both mother and child with significant morbidity and mortality rates. The mechanisms leading to acute or fulminant liver failure in pregnant patients still remain elusive. Compared to developing countries, industrialized nations have very few reported cases of HEV infection during pregnancy. Immediate hospitalization is recommended for suspected cases, and liver transplantation is the only option for who develop acute or fulminant liver failure. Ribavirin is the only drug of choice that is however, contraindicated during pregnancy because of severe side-effects and the risk of teratogenicity.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Journal of Gastroenterology and Hepatology Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
